223 related articles for article (PubMed ID: 12503945)
1. Aspirin dose for prevention of cardiovascular disease in diabetics.
Nowak SN; Jaber LA
Ann Pharmacother; 2003 Jan; 37(1):116-21. PubMed ID: 12503945
[TBL] [Abstract][Full Text] [Related]
2. The benefit of aspirin therapy in type 2 diabetes: what is the evidence?
Sirois C; Poirier P; Moisan J; Grégoire JP
Int J Cardiol; 2008 Sep; 129(2):172-9. PubMed ID: 18495263
[TBL] [Abstract][Full Text] [Related]
3. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis.
Stavrakis S; Stoner JA; Azar M; Wayangankar S; Thadani U
Am J Med Sci; 2011 Jan; 341(1):1-9. PubMed ID: 21191260
[TBL] [Abstract][Full Text] [Related]
4. Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.
Schnell O; Erbach M; Hummel M
Diab Vasc Dis Res; 2012 Oct; 9(4):245-55. PubMed ID: 22508698
[TBL] [Abstract][Full Text] [Related]
5. Effect of aspirin dose on mortality and cardiovascular events in people with diabetes: a meta-analysis.
Simpson SH; Gamble JM; Mereu L; Chambers T
J Gen Intern Med; 2011 Nov; 26(11):1336-44. PubMed ID: 21647746
[TBL] [Abstract][Full Text] [Related]
6. Prevention of cardiovascular disease in type-2 diabetes: how to improve the clinical efficacy of aspirin.
Evangelista V; Totani L; Rotondo S; Lorenzet R; Tognoni G; De Berardis G; Nicolucci A
Thromb Haemost; 2005 Jan; 93(1):8-16. PubMed ID: 15630484
[TBL] [Abstract][Full Text] [Related]
7. [Aspirin therapy for cardiovascular prevention in the diabetic patient: what have we learned from the evidence?].
Legrand DA; Scheen AJ
Rev Med Suisse; 2006 Aug; 2(76):1904-8. PubMed ID: 16972540
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes.
Bethel MA; Harrison P; Sourij H; Sun Y; Tucker L; Kennedy I; White S; Hill L; Oulhaj A; Coleman RL; Holman RR
Diabet Med; 2016 Feb; 33(2):224-30. PubMed ID: 26043186
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of high on-treatment platelet reactivity in diabetic patients treated with aspirin.
Simpson SH; Abdelmoneim AS; Omran D; Featherstone TR
Am J Med; 2014 Jan; 127(1):95.e1-9. PubMed ID: 24384107
[TBL] [Abstract][Full Text] [Related]
10. Aspirin for primary prevention of cardiovascular events in people with diabetes.
Pignone M; Alberts MJ; Colwell JA; Cushman M; Inzucchi SE; Mukherjee D; Rosenson RS; Williams CD; Wilson PW; Kirkman MS; ; ;
J Am Coll Cardiol; 2010 Jun; 55(25):2878-86. PubMed ID: 20579547
[No Abstract] [Full Text] [Related]
11. [Use of aspirin in diabetic patients].
Türkoğlu S; Abaci A
Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():5-8. PubMed ID: 18160360
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of cardiovascular diseases in type 2 diabetes with aspirin].
Duly-Bouhanick B; Menard S; Hadjadj S; Soares-Barbosa S; Plun-Favreau J; Guilloteau G
Presse Med; 2001 Jan; 30(2):87-91. PubMed ID: 11244821
[TBL] [Abstract][Full Text] [Related]
13. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
14. Does aspirin use reduce cardiovascular risk in diabetes?
Colwell JA
Nat Rev Endocrinol; 2009 Apr; 5(4):188-90. PubMed ID: 19352314
[TBL] [Abstract][Full Text] [Related]
15. Aspirin in cardiovascular disorders. What is the optimum dose?
Kong DF
Am J Cardiovasc Drugs; 2004; 4(3):151-8. PubMed ID: 15134467
[TBL] [Abstract][Full Text] [Related]
16. Aspirin dosing for the prevention and treatment of ischemic stroke: an indication-specific review of the literature.
Ansara AJ; Nisly SA; Arif SA; Koehler JM; Nordmeyer ST
Ann Pharmacother; 2010 May; 44(5):851-62. PubMed ID: 20388864
[TBL] [Abstract][Full Text] [Related]
17. [Primary prevention with aspirin for cardiovascular diseases in diabetic patients. What evidence supports the criteria of the ADA?].
Maciá Bobes C; Ronzón Fernández A; Fernández García E
Aten Primaria; 2007 Mar; 39(3):163-4. PubMed ID: 17386212
[No Abstract] [Full Text] [Related]
18. Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis.
Zhang C; Sun A; Zhang P; Wu C; Zhang S; Fu M; Wang K; Zou Y; Ge J
Diabetes Res Clin Pract; 2010 Feb; 87(2):211-8. PubMed ID: 19853947
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular pharmacology core reviews: aspirin.
Gaglia MA; Clavijo L
J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):505-13. PubMed ID: 24057863
[TBL] [Abstract][Full Text] [Related]
20. [Aspirin in cardiovascular prevention: does the approach differ by gender?].
Temizhan A
Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():2-4. PubMed ID: 18160359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
